Publication:
A novel loss-of-function mutation of PBK associated with human kidney stone disease

dc.contributor.authorChoochai Nettuwakulen_US
dc.contributor.authorNunghathai Sawasdeeen_US
dc.contributor.authorOranud Praditsapen_US
dc.contributor.authorNanyawan Rungrojen_US
dc.contributor.authorArnat Pasenaen_US
dc.contributor.authorThanyaporn Dechtawewaten_US
dc.contributor.authorNipaporn Deejaien_US
dc.contributor.authorSuchai Sritippayawanen_US
dc.contributor.authorSanti Rojsatapongen_US
dc.contributor.authorWipada Chaowagulen_US
dc.contributor.authorPa thai Yenchitsomanusen_US
dc.contributor.otherSappasitthiprasong Hospitalen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.date.accessioned2020-08-25T12:00:45Z
dc.date.available2020-08-25T12:00:45Z
dc.date.issued2020-12-01en_US
dc.description.abstract© 2020, The Author(s). Kidney stone disease (KSD) is a prevalent disorder that causes human morbidity worldwide. The etiology of KSD is heterogeneous, ranging from monogenic defect to complex interaction between genetic and environmental factors. Since mutations of genes responsible for KSD in a majority of families are still unknown, our group is identifying mutations of these genes by means of genomic and genetic analyses. In this study, we identified a novel loss-of-function mutation of PBK, encoding the PDZ binding kinase, that was found to be associated with KSD in an affected Thai family. Glycine (Gly) substituted by arginine (Arg) at position 43 (p.Gly43Arg) in PBK cosegregated with the disease in affected members of this family, but was absent in 180 normal control subjects from the same local population. Gly43 is highly evolutionarily conserved in vertebrates, and its substitution affects protein structure by alterations in H-bond forming patterns. This p.Gly43Arg substitution results in instability of the variant PBK protein as examined in HEK293T cells. The variant PBK protein (p.Gly43Arg) demonstrated decreased kinase activity to phosphorylate p38 MAPK as analyzed by immunoblotting and antibody microarray techniques. Taken together, these findings suggest a possible new mechanism of KSD associated with pathogenic PBK variation.en_US
dc.identifier.citationScientific Reports. Vol.10, No.1 (2020)en_US
dc.identifier.doi10.1038/s41598-020-66936-4en_US
dc.identifier.issn20452322en_US
dc.identifier.other2-s2.0-85087055217en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/58395
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087055217&origin=inwarden_US
dc.subjectMultidisciplinaryen_US
dc.titleA novel loss-of-function mutation of PBK associated with human kidney stone diseaseen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087055217&origin=inwarden_US

Files

Collections